Search details
1.
Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity.
Blood
; 122(1): 134-42, 2013 Jul 04.
Article
in English
| MEDLINE | ID: mdl-23699598
2.
Substrates of Factor XIII-A: roles in thrombosis and wound healing.
Clin Sci (Lond)
; 124(3): 123-37, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23075332
3.
α-α Cross-links increase fibrin fiber elasticity and stiffness.
Biophys J
; 102(1): 168-75, 2012 Jan 04.
Article
in English
| MEDLINE | ID: mdl-22225811
4.
Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion.
Blood
; 115(13): 2674-81, 2010 Apr 01.
Article
in English
| MEDLINE | ID: mdl-20086247
5.
The pleiotropic role of the fibrinogen gamma' chain in hemostasis.
Blood
; 114(19): 3994-4001, 2009 Nov 05.
Article
in English
| MEDLINE | ID: mdl-19687509
6.
Transglutaminase 2 limits the extravasation and the resultant myocardial fibrosis associated with factor XIII-A deficiency.
Atherosclerosis
; 294: 1-9, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31874419
7.
Role of proteomic technologies in understanding risk of arterial thrombosis.
Expert Rev Proteomics
; 6(5): 539-50, 2009 Oct.
Article
in English
| MEDLINE | ID: mdl-19811075
8.
Heritability of clot formation.
Semin Thromb Hemost
; 35(5): 458-67, 2009 Jul.
Article
in English
| MEDLINE | ID: mdl-19739036
9.
Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation.
Br J Haematol
; 160(1): 116-9, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23078103
10.
Fibrin clot structure in patients with end-stage renal disease.
Thromb Haemost
; 98(2): 339-45, 2007 Aug.
Article
in English
| MEDLINE | ID: mdl-17721616
11.
BßArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
Thromb Haemost
; 117(2): 295-302, 2017 01 26.
Article
in English
| MEDLINE | ID: mdl-27929198
12.
The molecular physiology and pathology of fibrin structure/function.
Blood Rev
; 19(5): 275-88, 2005 Sep.
Article
in English
| MEDLINE | ID: mdl-15963835
13.
Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function.
Circulation
; 107(18): 2326-30, 2003 May 13.
Article
in English
| MEDLINE | ID: mdl-12707238
14.
The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation.
Diabetes
; 51(1): 189-97, 2002 Jan.
Article
in English
| MEDLINE | ID: mdl-11756340
15.
Normal Bone Deposition Occurs in Mice Deficient in Factor XIII-A and Transglutaminase 2.
Matrix Biol
; 43: 85-96, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25680676
16.
Elevated properdin and enhanced complement activation in first-degree relatives of South Asian subjects with type 2 diabetes.
Diabetes Care
; 35(4): 894-9, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-22338105
17.
Complement C3 is a novel plasma clot component with anti-fibrinolytic properties.
Diab Vasc Dis Res
; 9(3): 216-25, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22253322
18.
Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity.
Blood
; 111(2): 643-50, 2008 Jan 15.
Article
in English
| MEDLINE | ID: mdl-17925485
19.
Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness.
Blood
; 110(3): 902-7, 2007 Aug 01.
Article
in English
| MEDLINE | ID: mdl-17435113
20.
Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure.
Blood
; 102(2): 535-40, 2003 Jul 15.
Article
in English
| MEDLINE | ID: mdl-12663453